Weight Loss Medications · Tool Face-Off

Ozempic vs Saxenda

Quick answer

Both are GLP-1 receptor agonists that curb appetite, but Ozempic (semaglutide) wins on weight loss efficacy and once-weekly convenience, while Saxenda (liraglutide) has a longer safety track record specifically for obesity and wider insurance coverage for weight management.

Our pick

Ozempic

Once-weekly semaglutide — diabetes drug moonlighting as a weight-loss superstar

4★

Saxenda

Daily liraglutide — the OG GLP-1 approved specifically for chronic weight management

3.6★

Active Ingredient

Semaglutide

Liraglutide

Injection Frequency

Once weekly

Once daily

FDA Approval (Obesity)

No — diabetes label (Wegovy is the obesity version)

Yes — approved for chronic weight management

Average Weight Loss

~15% body weight (trial data)

~5-8% body weight (trial data)

List Price (monthly)

~$900-$1,000/month

~$1,300-$1,500/month

Insurance Coverage (Weight Loss)

Often denied — diabetes indication only

More likely covered for obesity diagnosis

Starting Dose

0.25 mg weekly

0.6 mg daily

Max Dose

2 mg/week

3 mg/day

Common Side Effects

Nausea, vomiting, diarrhea

Cardiovascular Outcomes Data

SUSTAIN trials (strong CV benefit)

LEADER trial (proven CV benefit)

Supply Shortages

Frequent — very high demand

Relatively stable supply

Pen Device

Prefilled, easy dial-a-dose

Prefilled daily pen

Ozempic

Availability★★★☆☆

Dosing Convenience★★★★★

Side Effect Profile★★★½☆

Appetite Suppression★★★★★

Weight Loss Efficacy★★★★½

Long-Term Safety Data★★★★☆

Cost & Insurance Access★★★☆☆

Saxenda

Availability★★★★☆

Dosing Convenience★★½☆☆

Side Effect Profile★★★½☆

Appetite Suppression★★★½☆

Weight Loss Efficacy★★★½☆

Long-Term Safety Data★★★★½

Cost & Insurance Access★★★½☆

Worth knowing

Ozempic can reduce body weight by ~15% on average vs ~5-8% for Saxenda in clinical trials.
Saxenda is FDA-approved specifically for obesity (BMI ≥30 or ≥27 with a condition); Ozempic officially is not.
Both drugs cause nausea most commonly in the first 4-8 weeks as doses ramp up.
Wegovy — the obesity-approved twin of Ozempic — uses the same semaglutide but at higher doses up to 2.4 mg.
Ozempic shortages have been widespread since 2022 due to explosive off-label demand.

Ozempic became so culturally famous that 'Ozempic face' — gaunt cheeks from rapid fat loss — entered the beauty industry's vocabulary, spawning a new wave of filler appointments.

If you want

You want maximum weight loss and weekly dosing

Ozempic (or its obesity twin Wegovy) delivers roughly double the weight loss of Saxenda with far more convenient once-weekly injections.

→ Pick Ozempic

If you want

You need insurance to actually cover your medication

Saxenda is FDA-approved for obesity, making it easier to justify to insurers than off-label Ozempic prescriptions.

→ Pick Saxenda

If you want

You hate daily injections and have supply flexibility

One shot a week beats 365 shots a year — and semaglutide's potency means fewer dose escalations needed.

→ Pick Ozempic